{
    "2020-06-02": [
        [
            {
                "time": "",
                "original_text": "医药生物行业点评报告：ASCO 2020全球进展解读：免疫疗法依旧亮眼，联合用药大势所趋",
                "features": {
                    "keywords": [
                        "医药生物",
                        "ASCO",
                        "全球进展",
                        "免疫疗法",
                        "联合用药"
                    ],
                    "sentiment_score": 0.75,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药",
                        "生物科技"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": ""
                }
            }
        ]
    ]
}